NASDAQ:BKYI
Bio Key International Inc.
Bio Key International Inc.'s revenue fell 14.3% in fiscal 2025 to $5.9M while operating margin fell to −115.0%. Free cash flow was −$4.7M, −78.8% of revenue.Summary generated from Bio Key International Inc.'s SEC filings. Latest annual report filed Jun 12, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$5.9M
Revenue growth−14.3%
Revenue, 5-yr CAGR+15.9%
Gross margin76.9%
Operating margin−115.0%
Net margin−120.6%
ROICn/a
Return on equity−161.2%
Debt / equityn/a
Free cash flow−$4.7M
FCF margin−78.8%
Share count changen/a
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 | 7 | 8 | 7 | 6 |
| Operating income | −5 | −10 | −9 | −4 | −7 |
| Net income | −5 | −12 | −9 | −4 | −7 |
| Free cash flow | −9 | −6 | −4 | −3 | −5 |
Recent filings
- S-1Registration statement
Oct 9, 2026 - 8-KResults of a shareholder vote
Oct 6, 2026 - 8-KEntry into a material agreement
Oct 2, 2026 - 8-KOther events
Sep 8, 2026 - 8-KResults of operations and financial condition
Aug 14, 2026 - 8-KEntry into a material agreement
Aug 13, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 13, 2026 - DEF 14AProxy statement
Jul 24, 2026